Revolution Medicines Income from Continuous Operations 2018-2025 | RVMD
Revolution Medicines income from continuous operations for the twelve months ending March 31, 2025 was $-0.698B, a 44.03% increase year-over-year.
- Revolution Medicines annual income from continuous operations for 2024 was $-0.6B, a 37.52% increase from 2023.
- Revolution Medicines annual income from continuous operations for 2023 was $-0.436B, a 75.46% increase from 2022.
- Revolution Medicines annual income from continuous operations for 2022 was $-0.249B, a 32.93% increase from 2021.